Three cDNA fragments corresponding to codons 164-557 (N),
681-1072 (M), and 1671-2095 (C) of predicted Rp1 protein sequence were
chosen to make His-tagged proteins using the pET-30a(+) vector
(Novagen, Madison, WI;
Fig. 2A ). Three smaller fragments corresponding to codons 386-559 (N′), 708-894
(M′), and 1708-1928 (C′) within the above regions were also produced
for making glutathione-
S-transferase (GST) fusion proteins
using the pGEX5.1 vector (Amersham Pharmacia, Arlington Heights, IL;
Fig. 2B ). To produce these fusion proteins, the indicated regions of
Rp1 cDNA were amplified by PCR from a full-length
Rp1 cDNA clone, using primers containing the desired
restriction enzyme recognition sites. PCR products were digested with
the appropriate restriction enzymes and subcloned into the pET-30a(+)
or pGEX-5.1 vectors. BL21 (DE3)
Escherichia coli (Novagen)
was used to produce fusion proteins according to the manufacturer’s
recommendations. All six fusion proteins were found to form inclusion
bodies and thus to be insoluble. Two different methods were used for
purifying these fusion proteins. For His-tagged fusion proteins, the
bacterial lysates were extracted, using a binding buffer (500 mM NaCl,
6 M urea in 20 mM phosphate buffer [pH 7.4]), and affinity-purified
using His-Trap columns (Amersham Pharmacia). Purified fusion proteins
were eluted with imidazole, dialyzed against PBS with 2 M urea at
4°C, and concentrated. For GST fusion proteins, bacterial protein
extracts in SDS sample buffer were separated by
SDS-PAGE.
15 The gels were transiently stained with a
copper staining kit (Bio-Rad, Hercules, CA). The overexpressed fusion
proteins of the correct size were cut out of the gel, destained, and
eluted in an elution buffer (50 mM Tris-Cl [pH 7.5], 150 mM NaCl,
0.1% SDS, and 0.1 mM EDTA) for 1 hour at room temperature. The eluate
was filtered by a syringe and dialyzed against PBS for 24 hours at
4°C. Purified proteins were used to immunize animals.